Raymond James Reiterates Strong Buy Rating on Vir Biotechnology (VIR)

September 28, 2026 2:03 PM EDT Send to a Friend
Raymond James analyst Sean McCutcheon reiterated a Strong Buy rating and $19.00 price target on Vir Biotechnology (NASDAQ: VIR).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login